Journals / Turkish Thoracic Journal / 2020 / Cilt: 21 - Sayı: 1

Change in Pulmonary Function Following Decortication for Chronic Pleural Empyema

Pages
27–31
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Pre-operation spirometry values [mean forced expiratory volume in1s (FEV1) and mean forced vital capacity (FVC)] were compared with the post-operation data obtained during follow-up and the changewas quantified by statistical analysis.RESULTS: FEV1 was 70.51% before surgery vs. 83.43% after surgery (p 0.01).CONCLUSION: Decortication and pleurectomy via a posterolateral thoracotomy resulted in significant clinico-functional improvementin patients with chronic empyema, regardless of the bacteriology, side of occurrence of the lesion, smoking habit, or diabetic status ofthe patient.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:OBJECTIVES: Chronic empyema is the final stage of the triphasic pathogenesis of empyema that is characterized by fibrin deposits in bothpleural surfaces, leading to the formation of a thickened pleural peel.
📊
Key Findings & Data:The aim of this study was to determine the change in pulmonary function following decorticationfor chronic empyema.MATERIALS AND METHODS: A total of 35 patients with chronic pleural empyema who underwent decortication via a posterolateralthoracotomy between July 2016 and July 2017 were reviewed and followed-up for 6±3 months after surgery.
💡
Conclusion & Impact:Pre-operation spirometry values [mean forced expiratory volume in1s (FEV1) and mean forced vital capacity (FVC)] were compared with the post-operation data obtained during follow-up and the changewas quantified by statistical analysis.RESULTS: FEV1 was 70.51% before surgery vs. 83.43% after surgery (p 0.01).CONCLUSION: Decortication and pleurectomy via a posterolateral thoracotomy resulted in significant clinico-functional improvementin patients with chronic empyema, regardless of the bacteriology, side of occurrence of the lesion, smoking habit, or diabetic status ofthe patient.
🔬Design:Review & Systematic Survey
📍Scope:2016 Verileri
⚙️Variables:Domain Parameters

Özet

OBJECTIVES: Chronic empyema is the final stage of the triphasic pathogenesis of empyema that is characterized by fibrin deposits in bothpleural surfaces, leading to the formation of a thickened pleural peel. This restricts the lung movements, giving rise to a trapped lung andimpairment of pulmonary function. The aim of this study was to determine the change in pulmonary function following decorticationfor chronic empyema.MATERIALS AND METHODS: A total of 35 patients with chronic pleural empyema who underwent decortication via a posterolateralthoracotomy between July 2016 and July 2017 were reviewed and followed-up for 6±3 months after surgery. All patients underwent apulmonary function test using spirometry before and after surgery. Pre-operation spirometry values [mean forced expiratory volume in1s (FEV1) and mean forced vital capacity (FVC)] were compared with the post-operation data obtained during follow-up and the changewas quantified by statistical analysis.RESULTS: FEV1 was 70.51% before surgery vs. 83.43% after surgery (p 0.01).CONCLUSION: Decortication and pleurectomy via a posterolateral thoracotomy resulted in significant clinico-functional improvementin patients with chronic empyema, regardless of the bacteriology, side of occurrence of the lesion, smoking habit, or diabetic status ofthe patient.

🔖

Cite This Article

ABRAHAM, S. V., CHIKKAHONNAIAH, P. (2020). Change in Pulmonary Function Following Decortication for Chronic Pleural Empyema. Turkish Thoracic Journal, Cilt: 21 - Sayı: 1, 27–31. https://ajindex.com/articles/417928

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Light RW. Parapneumonic effusions and empyema. Proc Am Thorac Soc 2006;3:75-80. [CrossRef] 2. Brook I, Frazier EH. Aerobic and anaerobic microbiology of empyema. A retrospective review in two military hospitals. Chest 1993;103:1502-7. [CrossRef] 3. Ferguson AD, Prescott RJ, Selkon JB, et al. The clinical course and management of thoracic empyema. QJM 1996;89:285-9. [CrossRef] 4. Molnar TF. Current surgical treatment of thoracic empyema in adults. Eur J Cardiothorac Surg 2007;32:422-30. [CrossRef] 5. Alegre RA, Garisto GD, Zobede S. Open thoracotomy and decortication for chronic empyema. Clinics 2008;63:789-93. [CrossRef] 6. Thourani VH, Brady KM, Mansour K, et al. Evaluation of treatment modalities for thoracic empyema: cost effective analysis. Ann Thoracic Surg 1998;66:1121-7. [CrossRef] 7. Soraino T, Alegre J, Aleman C, et al. Factors influencing the hospital stay in patients with bacterial pleural effusion. Respiration 2005;72:587-93. [CrossRef] 8. LeMense GP, Strange C, Sahn SA. Empyema thoracis: Therapeutic management and outcome. Chest 1995;107:1532-7. [CrossRef] 9. Melloni G, Carretta A, Ciriaco P, et al. Decortication for chronic parapneumonic empyema: results of a prospective study. World J Surg 2004;28:488-93. [CrossRef] 10. Choi SS, Kim DJ, Kim KD, et al. Change in pulmonary function following empyemectomy and decortication in tuberculous and non-tuberculous chronic empyema thoracis. Yonsei Med J 2004;45:643-8. [CrossRef] 11. Rzyman W., Skokowski J., Romanowicz G, et al. Decortication in chronic pleural empyema-effect on lung function Eur J of Cardiothorac Surg 2002;21:502-7. [CrossRef] 12. Gokce M, Okur E, Baysungur V, et al. Lung decortication for chronic empyaema: effects on pulmonary function and thoracic asymmetry in the late period. Eur J Cardiothorac Surg 2009;36:754-8. [CrossRef] 13. Rai SP, Kaul SK, Tripathi RK, et al. Decortication in chronic pleural empyema. Lung India 2006;23:100-2. [CrossRef] 14. Andrews NC, Parker EF, Shaw RR, et al. Management of Nontuberculous empyema. Am Rev Respir Dis 1962;85:935-6. 15. LeMense GP, Strange C, Sahn SA. Empyema thoracic, therapeutic management and outcome. Chest 1995;107:1532-7. [CrossRef] 16. Thourani VH, Brady KM, Mansour K, et al. Evaluation of treatment modalities for thoracic empyema: cost effective analysis. Ann Thoracic Surg 1998;66:1121-7. [CrossRef] 17. Mouroux J, Maalouf J, Padovani B, et al. Surgical management of pleuropulmonary tuberculosis. J Thorac Cardiovasc Surg 1996;111:662-7